News
Personalized Stem Cells Announces Completion of Enrollment for FDA Approved Stem Cell Clinical Trial for Knee Arthritis
Personalized Stem Cells, Inc (PSC), a human adipose-derived stem cell company, has announced that enrollment is officially complete for their FDA approved stem cell clinical trial for treatment of knee osteoarthritis. 38 patients are participating in the clinical...
Personalized Stem Cells Receives FDA Approval to Treat COVID-19 Patients
Personalized Stem Cells, Inc. receives FDA approval to treat COVID-19 patients with stem cells.
Personalized Stem Cells Secures $2.5 Million in Series A Financing Round
San Diego based stem cell company, Personalized Stem Cells, Inc. secures $2.5 million in Series A financing round.
Personalized Stem Cells, Inc. Proceeds with Stem Cell Trial for Knee Osteoarthritis
Personalized Stem Cells, Inc. proceeds with FDA approved stem cell trial for knee osteoarthritis with new safety precautions amid COVID-19 pandemic.
Personalized Stem Cells Peer-Reviewed Paper: Stem Cell Therapy for COVID-19
Personalized Stem Cells, Inc. peer-reviewed paper published in the Journal of Translational Medicine supporting stem cell therapy for COVID-19 patients.
La Jolla native seeks speedy FDA approval for COVID-19 stem cell treatment
La Jolla native Dr. Bob Harman is applying his expertise in the veterinary and biotech fields to developing a stem cell treatment for COVID-19.
San Diego biotech firm seeks approval for stem cell research against COVID-19
Personalized Stem Cells Incorporated (PSC) in Poway said the therapy could reduce the most serious complications of the infection in the lungs.
Ramona resident seeks speedy FDA approval for COVID-19 stem cell treatment
As CEO of Personalized Stem Cells, Inc. in Poway, Dr. Harman is involved in the company’s quest to have the Food & Drug Administration (FDA) fast-track its Investigational New Drug application for the treatment of COVID-19 patients with stem cells.
COVID-19 Stem Cell Treatments – Urgent Charitable Donations Call
Donations needed to ramp up stem cell production to provide treatments for COVID-19 patients.
CoronaStem 1 Trial – Personalized Stem Cells Files for Expedited FDA Approval to Treat COVID-19 Patients
Personalized Stem Cells, Inc. (PSC) and its parent company, VetStem Biopharma, have filed an expedited review request for an Investigational New Drug (IND) application with the FDA for the treatment of COVID-19 patients with stem cells. The first trial is named...